Search clinical trials for: Hydroxychloroquine Sulfate 400Mg Tab

Total 250 results

National Institute of Allergy and Infectious Diseases...

Not yet recruiting

CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy

Pregnancy | HIV-1-infection | Postpartum

United States, South Africa
Lionel.D.Lewis, MD
Dartmouth Cancer Center

Not yet recruiting

HCQ in Resectable Localized Prostate Cancer

Resectable Localized Prostate Cancer
Patrick Hensley

Active, not recruiting

Hydroxychloroquine to Increase Tumor Suppressor PAR-4 Levels in Oligometastatic Prostate Cancer

Prostate Cancer Recurrent

United States
Bukwang Pharmaceutical

Completed

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Healthy Adult Male

Korea, Republic of
Yuhan Corporation

Completed

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Peripheral Artery Disease, PAD

Korea, Republic of
Peng Wang, MD PhD

Completed

HCQ on PAR-4 Levels in Patients With Resectable Solid Tumors

Solid Tumor

United States
Samyang Biopharmaceuticals Corporation
Severance Hospital

Completed

Crossover Study to Compare Pharmacokinetic Property of SYO-1126 and Glivec Film Coated Tab in Healthy Male Volunteers

Healthy

Korea, Republic of
Hanlim Pharm. Co., Ltd.

Completed

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

Healthy Male Subjects

Korea, Republic of
Tan Tock Seng Hospital
Netherlands: Ministry of Health, Welfare and Sports; Duke-NUS Graduate Medical... and other collaborators

Withdrawn

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19 (SHARP COVID-19)

Coronavirus Infection | Hydroxychloroquine Adverse Reaction
Shaheed Zulfiqar Ali Bhutto Medical University

Unknown

Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 (CHEER)

COVID 19

Pakistan
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
Shanghai Children's Hospital

Recruiting

Study of Hydroxychloroquine in Patients With X-linked Alport Syndrome in China (CHXLAS) (CHXLAS)

Alport Syndrome, X-Linked

China
Shaheer A. Khan
AstraZeneca; Melanoma Research Alliance

Completed

Intermittent Selumetinib for Uveal Melanoma

Uveal Melanoma

United States
Children's Hospital of Fudan University

Recruiting

Hydroxychloroquin (HCQ) in chILD of Genetic Defect

Surfactant Dysfunction

China
Ravi Amaravadi, MD

Terminated

The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) (PATCH)

COVID-19

United States
Health Institutes of Turkey

Completed

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Covid19

Turkey
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers

Hypertension | Dyslipidemias

Korea, Republic of
HK inno.N Corporation

Completed

Study to Confirm the Safety and Efficacy of CJ-12420 in Patients With Erosive Esophagitis

Erosive Esophagitis

Korea, Republic of
Radboud University Medical Center
Merck Sharp & Dohme LLC; ZonMw: The Netherlands Organisation for Health Research...

Recruiting

Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers (PANNA-B PK)

Hiv

Netherlands
Genuine Research Center, Egypt
Bio Med for Pharmaceuticals Industries (BIOMED), Egypt

Completed

Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

Healthy

Egypt
Universidad Nacional Andres Bello

Completed

Efficacy of Azithromycin as an Adjunct to Non-Surgical Periodontal Treatment

Periodontitis

Chile
Apsen Farmaceutica S.A.
Federal University of São Paulo

Withdrawn

Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19)

Coronavirus Infections | SARS-CoV 2 | Pulmonary Disease | SARS (Severe Acute Respiratory Syndrome)

Brazil
Government of Punjab, Specialized Healthcare and...
Harvard School of Public Health (HSPH); Forman Christian College, Pakistan; Services... and other collaborators

Terminated

Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds (PEACE)

COVID-19 | Coronavirus Infection | SARS-CoV-2 | Asymptomatic Condition

Pakistan
Sandoz

Completed

To Demonstrate the Relative Bioavailability of Hydroxychloroquine Sulfate, 200 mg Tablets

Immunosuppression | Rheumatism
Chong Kun Dang Pharmaceutical

Completed

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Non-erosive Reflux Disease(NERD)

Korea, Republic of
Rutgers, The State University of New Jersey

Terminated

Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19

COVID-19 | SARS-CoV-2

United States
Government of Punjab, Specialized Healthcare and...
Services Hospital, Lahore; Mayo Hospital Lahore; Pakistan Kidney and Liver Institute

Terminated

PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds (PRECISE)

Covid-19 | Sars-CoV2 | Symptomatic Condition

Pakistan
Yuhan Corporation

Completed

Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease

Arterial Occlusive Diseases | Intermittent Claudication

Korea, Republic of
Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Switch Strategy From Etravirine (ETR) to Doravirine (DOR) in Virologically-Suppressed HIV-1 Infected Adults With ETR-Resistance

HIV-1-infection

Spain
Chong Kun Dang Pharmaceutical

Completed

CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1)

Diabetes Mellitus Type 2

Korea, Republic of
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions

Healthy

Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Withdrawn

Acute Rhabdomyolysis and Muscle Pain Associated With Mutations in the LPIN1 Gene - A Retrospective Study Describing the Safety and Efficacy of Hydroxychloroquine Sulfate Given on a Compassionate Basis to Patients Suffering From Lipin-1 Deficiency (LIPIN-1-METAB)

LIPIN1 Deficiency

France
Chong Kun Dang Pharmaceutical

Completed

Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects

Diabetes Mellitus, Type 2

Korea, Republic of
Hackensack Meridian Health

Completed

Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers

Covid19

United States
Peking University First Hospital

Completed

A Study of Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy

Hydroxychloroquine | IgA Patients

China
LLiu

Completed

Hydroxychloroquine Sulfate for Reduction of Proteinuria in Patients With IgA Nephropathy: a Self- Controlled Study

Primary IgA Nephropathy

China
Hanlim Pharm. Co., Ltd.

Recruiting

Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD)

Chronic Venous Disease

Korea, Republic of
dora pereira
University of Oxford; University of Cambridge; Bangor University

Completed

Health Economics of the Use of Ferrous Iron Salts in Primary Care in the UK.

Anemia

United Kingdom
Sidney Kimmel Comprehensive Cancer Center at Johns...
Novartis Pharmaceuticals; The Skip Viragh Foundation

Terminated

Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Pancreatic Ductal Adenocarcinoma

United States
University Hospital Tuebingen
Universitätsklinikum Hamburg-Eppendorf; Robert Bosch Medical Center; Bernhard...

Terminated

Hydroxychloroquine for COVID-19 (COV-HCQ)

COVID-19, Hydroxychloroquine Sulfate

Germany
Texas Cardiac Arrhythmia Research Foundation

Withdrawn

Prophylactic Benefit of Hydroxychloroquine in COVID-19 Cases With Mild to Moderate Symptoms and in Healthcare Workers With High Exposure Risk (PREVENT)

COVID-19
Daewoong Pharmaceutical Co. LTD.

Completed

A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions

Healthy

Korea, Republic of
Second Affiliated Hospital, School of Medicine,...

Recruiting

The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Shanghai First Maternity and Infant Hospital
Fudan University; Xinhua Hospital, Shanghai Jiao Tong University School of... and other collaborators

Not yet recruiting

A Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Spontaneous Abortion With Antiphospholipid Syndrome

Recurrent Miscarriage | Antiphospholipid Syndrome

China
Fortune Pharmacal Co., Ltd.
Chinese University of Hong Kong

Completed

Clinical Bioequivalence Study on Two Paracetamol Tablet Formulations

Healthy

Hong Kong
Cambridge University Hospitals NHS Foundation Trust
University of Cambridge

Withdrawn

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion (PROTECT)

COVID-19
First Affiliated Hospital of Harbin Medical University

Unknown

Effect of Hydroxychloroquine on Atrial Fibrillation Recurrence

Atrial Fibrillation

China
Chong Kun Dang Pharmaceutical

Completed

A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunteers

Diabetes Mellitus, Type II

Korea, Republic of
West Virginia University

Recruiting

Neoadjuvant mFOLFIRINOX With Perioperative Oral Hydroxychloroquine in Resectable Pancreatic Adenocarcinoma

Adenocarcinoma of the Pancreas

United States
Tibotec Pharmaceuticals, Ireland

Completed

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

HIV Infections

Search clinical trials for: Hydroxychloroquine Sulfate 400Mg Tab

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations